Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

Written by

in

Reference: Loi S, Sirtaine N, Piette F, Salgado R, Viale G, Van Eenoo F, et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Mar 1;31(7):860-7. PubMed PMID: 23341518.

Tumor-infiltrating lymphocyte (TIL) 을 H&E 슬라이드만을 가지고 평가할 수 있다니..

뭐 못할건 없겠지만..

좀 용감한 듯…

Comments

Leave a Reply

More posts